Conditions: Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 103
Healthy volunteers: no

Brief summary:
A study to assess the safety and efficacy of sitagliptin 100mg compared to sitagliptin 200mg in patients with type 2 diabetes.

Detailed description:

Arms:
arm 1: sitagliptin 100 mg arm 2: sitagliptin 200 mg arm 3: Placebo

Interventions: intervention 1: sitagliptin phosphate intervention 2: sitagliptin phosphate intervention 3: Comparator: Placebo
Intervention descriptions: intervention 1: sitagliptin 100 mg tablets q.d. (once daily) for 7 days. intervention 2: sitagliptin 200 mg tablets q.d. (once daily) for 7 days. intervention 3: sitagliptin 100 mg \& 200 mg matching Placebo tablets q.d. (once daily) for 7 days.

Protocol document: